Navigation Links
CWRU global TB expert receives prestigious Fulbright Scholar Award
Date:5/6/2010

Anna Maria Mandalakas, MD, MSEpi, associate professor of Pediatrics, Global Health and Epidemiology & Biostatistics at Case Western Reserve University School of Medicine, has been selected by the J. William Fulbright Foreign Scholarship Board to receive a 2010 U.S. Fulbright Scholarship. Beginning in August 2010, Dr. Mandalakas will spend 11 months in Tygerberg, South Africa in collaboration with Stellenbosch University to study the benefits of Isoniazid preventative therapy (IPT) on children infected with Mycobacterium tuberculosis. Specifically, she will work to fill the gap between research and practice in the field of childhood tuberculosis focusing specifically on preventive therapy.

The core Fulbright Scholar Program sends 800 U.S. faculty and professionals abroad each year. While abroad, Fulbright Award recipients are encouraged to progress their education through a number of academic and professional fields. As a distinguished Senior Fulbright Scholar, Dr. Mandalakas will analyze the social and economic barriers to the practical implementation of Isoniazid preventive therapy. In conjunction with that research, Dr. Mandalakas will participate in the education of medical students, research staff, and physicians while hosting a seminar series on designing clinical research.

"It's a wonderful opportunity to enrich my ongoing translational research with another dimension of operational research," says Dr. Mandalakas, a pediatrician with Rainbow Babies and Children's Hospital at University Hospitals Case Medical Center. "While implementing our present research in South Africa, we are so frustrated as we witness children not receiving the therapy we recommend that can prevent them from getting very sick. This Fulbright funded research is an opportunity to actually address that problem and hopefully make a difference in the health of many children."

A recognized international expert, Dr. Mandalakas has focused her work over the last fourteen years on the identification of children with latent tuberculosis infection, when a patient is infected with tuberculosis but the disease has not yet progressed into the active stage. Children are at greater risk of developing the disease from the infection stage. Dr. Mandalakas will be researching the diagnostics of infection and then translating her findings to the delivery of preventative therapy, which is challenging in a country with very few health care resources. She will examine why preventative therapy is underutilized in South Africa specifically by exploring the knowledge, attitudes and behaviors of parents and health professionals. A portion of her work abroad will be advocacy to promote implementation of preventive therapy in the country.

"The Fulbright Foreign Scholarship Board could not have selected a better candidate than Dr. Mandalakas," said James Kazura, MD, director, Center for Global Health and Diseases and director, Director of International Affairs in Health Sciences at Case Western Reserve University. "Her dedication to combating tuberculosis, tireless work ethic, and extensive field experience serve as not only a reflection of Case Western Reserve School of Medicine, but as a testament to her high caliber. Anna will make an outstanding ambassador to South Africa."

Established in 1946 by then-U.S. Senator J. William Fulbright of Arkansas, the Fulbright Program is part of an international effort to promote and foster mutual understanding among 155 countries. Approximately 300,000 Fulbright Scholars have since participated in the Program collectively totaling 40 Nobel Prizes and hundreds of other notable awards.

The Fulbright Program is sponsored by the United States Department of State, Bureau of Educational and Cultural Affairs. Under a cooperative agreement with the Bureau, the Council for International Exchange of Scholars (CIES) assists in the administration of the Fulbright Scholar Program for faculty and professionals.


'/>"/>

Contact: Jessica Studeny
jessica.studeny@case.edu
216-368-4692
Case Western Reserve University
Source:Eurekalert

Related medicine news :

1. Protecting Global Travelers with New Security Solutions
2. Terumo Medical Corporation Announces its Program for the Global Embolization Symposium and Technologies (GEST) Meeting
3. Scott & White Healthcare physician to help develop global guidelines for Alzheimers
4. GlobalSign Announces First Successful E-Notarization in Ireland
5. Global Alliance of Technological Universities (GlobalTech) to tackle Grand Challenges
6. Reaching the tipping point on global child health
7. Super Fitness Bikini Model Mega-Mogul Jennifer Nicole Lee Goes Global, British TV Appearance, QVC London May 12th Sharing Top Fitness Products
8. Adult mortality trends reveal massive rise in global inequalities
9. First Annual Observance of World IBD Day Draws Awareness to Growing Global Incidence of Inflammatory Bowel Disease
10. Did SARS make China a more global player?
11. Study examines global availability of treatment involving transplantation of blood stem cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... The ... consultations to communities in the greater Denver region, is announcing a charity drive ... a very rare kind of epilepsy. , Until a few months ago, Dominik ...
(Date:7/21/2017)... ... July 21, 2017 , ... The Karen ... services to communities in the greater Birmingham area, is joining the Chris Hammond ... young people in the region. , The Chris Hammond Youth Foundation maintains athletic ...
(Date:7/21/2017)... PHILADELPHIA (PRWEB) , ... July 21, 2017 , ... ... ARTZ Philadelphia and Theater of Witness , was awarded a $300,000 ... growing humanities program which fosters empathy, comfort with ambiguity and the recognition of ...
(Date:7/21/2017)... ... July 21, 2017 , ... The Margarian Law Firm has filed a ... its ginger ale for allegedly containing no ginger. Dr. Pepper produces the “Canada Dry” ... plaintiff Gegham Margaryan alleges Canada Dry Ginger Ale claims on its bottle that it ...
(Date:7/21/2017)... , ... July 21, 2017 , ... ... medical students improve their chances of acceptance to a residency in a United ... have earned degrees outside the U.S. , According to data released by the ...
Breaking Medicine News(10 mins):
(Date:7/20/2017)... July 20, 2017  Prime Therapeutics LLC (Prime) released this ... M.D., following today,s Institute for Clinical and Economic Review,s (ICER) ... the effectiveness and value of abuse-deterrent formulations (ADF) of opioids. ... roundtable at the meeting. ... cost benefit to the use of abuse-deterrent formulations (ADF) in ...
(Date:7/14/2017)... LAS VEGAS , July 13, 2017 It ... the United States is in the midst of ... Disease Control , since 1999, the number of overdose deaths ... , "resulting in over half a million dead from 2001 ... like codeine, oxycodone, and hydrocodone has similarly quadrupled, drawing a ...
(Date:7/12/2017)... -- Eli Lilly and Company (NYSE: LLY ) has ... pending patent litigation in the U.S. District Court for the ... Cialis ® (tadalafil) unit dose patent. This patent was ... of the agreement, Cialis exclusivity is now expected to end ... unit dose patent for Cialis is valid and infringed by ...
Breaking Medicine Technology: